The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies

by Marica Meroni, Miriam Longo, Paola Dongiovanni
Published 2019-11-01

Alcohol or Gut Microbiota: Who Is the Guilty?

by Marica Meroni, Miriam Longo, Paola Dongiovanni
Published 2019-09-01

Mediterranean Diet and Sexual Health

by Miriam Longo, Paola Caruso, Katherine Esposito
Published 2020-12-01

Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease

by Marica Meroni, Miriam Longo, Paola Dongiovanni
Published 2020-08-01

Cardiometabolic risk factors in MASLD patients with HCC: the other side of the coin

by Marica Meroni, Miriam Longo, Paola Dongiovanni
Published 2024-05-01

The Non-Invasive Assessment of Circulating D-Loop and mt-ccf Levels Opens an Intriguing Spyhole into Novel Approaches for the Tricky Diagnosis of NASH

by Erika Paolini, Miriam Longo, Alberto Corsini, Paola Dongiovanni
Published 2023-01-01

Nutrition and Genetics in NAFLD: The Perfect Binomium

by Marica Meroni, Miriam Longo, Alice Rustichelli, Paola Dongiovanni
Published 2020-04-01

Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution

by Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni
Published 2022-03-01

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC

by Miriam Longo, Erika Paolini, Marica Meroni, Paola Dongiovanni
Published 2021-04-01

Genetics Is of the Essence to Face NAFLD

by Marica Meroni, Miriam Longo, Giada Tria, Paola Dongiovanni
Published 2021-09-01

Genetic and Epigenetic Modifiers of Alcoholic Liver Disease

by Marica Meroni, Miriam Longo, Raffaela Rametta, Paola Dongiovanni
Published 2018-12-01

MBOAT7 down-regulation by genetic and environmental factors predisposes to MAFLD

by Marica Meroni, Miriam Longo, Anna L. Fracanzani, Paola Dongiovanni
Published 2020-07-01

Sodium–glucose transporter-2 inhibitors for prevention and treatment of cardiorenal complications of type 2 diabetes

by Dario Giugliano, Miriam Longo, Lorenzo Scappaticcio, Paola Caruso, Katherine Esposito
Published 2021-01-01

GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off

by Dario Giugliano, Lorenzo Scappaticcio, Miriam Longo, Giuseppe Bellastella, Katherine Esposito
Published 2021-10-01

miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis

by Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani
Published 2018-12-01

Mediterranean Diet and COVID-19: Hypothesizing Potential Benefits in People With Diabetes

by Maria Ida Maiorino, Giuseppe Bellastella, Miriam Longo, Paola Caruso, Katherine Esposito
Published 2020-09-01

Genetics, Immunity and Nutrition Boost the Switching from NASH to HCC

by Paola Dongiovanni, Marica Meroni, Miriam Longo, Silvia Fargion, Anna Ludovica Fracanzani
Published 2021-10-01

Expanding the phenotypic spectrum of non-alcoholic fatty liver disease and hypertriglyceridemia

by Marica Meroni, Miriam Longo, Miriam Longo, Erika Paolini, Erika Paolini, Giada Tria, Michela Ripolone, Laura Napoli, Maurizio Moggio, Anna Ludovica Fracanzani, Anna Ludovica Fracanzani, Paola Dongiovanni
Published 2022-09-01

When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes

by Paola Caruso, Maurizio Gicchino, Miriam Longo, Lorenzo Scappaticcio, Ferdinando Campitiello, Katherine Esposito
Published 2022-01-01

Treating type 2 diabetes in COVID-19 patients: the potential benefits of injective therapies

by Miriam Longo, Paola Caruso, Maria Ida Maiorino, Giuseppe Bellastella, Dario Giugliano, Katherine Esposito
Published 2020-07-01